QUANTIFIED IMAGING LIMITED

14761622
Active United Kingdom

Research and experimental development on biotechnology

4 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Q

QUANTIFIED IMAGING LIMITED

14761622

Research and experimental development on biotechnology

Founded 27 Mar 2023 Active United Kingdom 4 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 16 Dec 2025 Next due 31 Mar 2027 9 months remaining
Confirmation Submitted 23 Apr 2026 Next due 9 Apr 2027 9 months remaining
Net assets £180K £45K 2025 year on year
Total assets £317K £62K 2025 year on year
Total Liabilities £137K £17K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Website

www.example.com

Full company profile for QUANTIFIED IMAGING LIMITED (14761622), an active life sciences and medical technology company based in United Kingdom. Incorporated 27 Mar 2023. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jul → 30 Jun 2025
Type total-exemption-full
Next accounts 30 Jun 2026
Due by 31 Mar 2027 9 months remaining

Net Assets, Total Assets & Total Liabilities (2024–2025)

Cash in Bank

£237.35k

Decreased by £49.69k (-17%)

Net Assets

£179.75k

Decreased by £44.84k (-20%)

Total Liabilities

£137.01k

Decreased by £17.40k (-11%)

Turnover

N/A

Employees

4

Debt Ratio

43%

Increased by 2 (+5%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Jun Year End
2024
30 Jun Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

136 Allotments 3,286,017 Shares £16.73m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Jul 20253,061£3.061£0.001
21 Jul 202541,763£256k£6.12
30 Jun 202534,749£191k£5.51
30 Jun 20258,979£55k£6.12
30 Jun 202534,749£191k£5.51

Officers

Officers

3 active
Status
Bruce, Hannah AmyDirectorBritishEngland341 Feb 2024Active
Kirk, Thomas Frank, DrDirectorBritishEngland3127 Mar 2023Active
Mcguire, BenDirectorAustralianGermany5314 Nov 2023Active

Shareholders

Shareholders (25)

Thomas Frank Kirk
26.6%
119,175
The University Of Nottingham
22.6%
100,979

Persons with Significant Control

Persons with Significant Control (4)

4 Active

Thomas Frank Kirk

British

Active
Notified 27 Mar 2023
Residence England
DOB August 1994
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Michael Alan Chappell

British

Active
Notified 27 Mar 2023
Residence England
DOB June 1981
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Dr Thomas Frank Kirk

British

Active
Notified 27 Mar 2023
Residence England
DOB August 1994
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Dr Michael Alan Chappell

British

Active
Notified 27 Mar 2023
Residence England
DOB June 1981
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
23 Apr 2026Confirmation StatementConfirmation statement made on 26 Mar 2026 with updates
21 Apr 2026OfficersAppointment of Dr Paul Justin Mussenden as director on 1 Feb 2025
8 Apr 2026CapitalAllotment of shares (GBP 447.511) on 10 Mar 2026
17 Mar 2026MiscellaneousReplacement filing of SH01 - 01/08/25 Statement of Capital gbp 402.687
19 Jan 2026CapitalAllotment of shares (GBP 402.687) on 1 Aug 2025
23 Apr 2026 Confirmation Statement

Confirmation statement made on 26 Mar 2026 with updates

21 Apr 2026 Officers

Appointment of Dr Paul Justin Mussenden as director on 1 Feb 2025

8 Apr 2026 Capital

Allotment of shares (GBP 447.511) on 10 Mar 2026

17 Mar 2026 Miscellaneous

Replacement filing of SH01 - 01/08/25 Statement of Capital gbp 402.687

19 Jan 2026 Capital

Allotment of shares (GBP 402.687) on 1 Aug 2025

Recent Activity

Latest Activity

Confirmation statement made on 26 Mar 2026 with updates

1 months ago on 23 Apr 2026

Appointment of Dr Paul Justin Mussenden as director on 1 Feb 2025

1 months ago on 21 Apr 2026

Allotment of shares (GBP 447.511) on 10 Mar 2026

2 months ago on 8 Apr 2026

Replacement filing of SH01 - 01/08/25 Statement of Capital gbp 402.687

2 months ago on 17 Mar 2026

Allotment of shares (GBP 402.687) on 1 Aug 2025

4 months ago on 19 Jan 2026